Imbio, a leading provider of artificial intelligence (AI) solutions for medical imaging analysis, and Heart&Lung Health, a leading cardiothoracic consultancy firm

Cybin Inc. (NEO:CYBN) (OTCQB:CLXPF) (“Cybin” or the “Company”), a biotechnology company focused on progressing psychedelic therapeutics

Four months after raising its seed round from Hoxton Ventures and dRX Capital, a venture arm of Novartis Pharma AG, Peptone, the molecular computational physics company